ReviewInternational journal of molecular sciences2025
From Biosynthesis to Legislation: A Review of Hydroxytyrosol's Biological Functions and Safety.
Review in International journal of molecular sciences, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- A comprehensive review ofRSC advances · 2026Review
- Exploring the associations between lifestyle and dietary patterns with preclinical alzheimer's disease: findings from La Rioja cohort study.European journal of nutrition · 2026Article
- Advances in Nanotechnological Strategies for Preserving and Authenticating Bioactive Compounds in Extra Virgin Olive Oil: Nano-Enabled Stabilization, Sensing, and Circular Valorization.Foods (Basel, Switzerland) · 2026Review
- Conversion of oleuropein to hydroxytyrosol by lactic acid bacteria fermentation of olive leaves in water solution with reduced glucose content.World journal of microbiology & biotechnology · 2025Article
- Valorization of Olive Oil and Wine Industry Byproducts: Challenges and Opportunities in Sustainable Food Applications.Foods (Basel, Switzerland) · 2025Review
- Exploring the Impact of Olive-Derived Bioactive Components on Gut Microbiota: Implications for Digestive Health.Foods (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Hydroxytyrosol (HT), a potent phenolic compound derived from olives, has attracted significant attention due to its exceptional antioxidant, anti-inflammatory, and antimicrobial properties. This review comprehensively examines recent advances in the synthesis, biological functions, safety profiles, and legal regulations of HT. We discuss both natural and biotechnological synthesis routes, including enzyme-mediated, non-transgenic, and transgenic biosynthetic methods, highlighting recent innovations that have improved yield and purity. The review further explores the multifaceted biological activities of HT, ranging from its role in cardiovascular protection and neuroprotection to its anticancer and metabolic regulatory effects. Safety assessments from animal and human studies are analyzed, demonstrating low toxicity and favorable metabolic profiles at physiologically relevant doses. Additionally, we compare international regulatory frameworks from the United States, China, and the European Union, which underscore the compound's safe use in food, pharmaceuticals, and cosmetics. Finally, the review outlines future research directions aimed at optimizing production methods, enhancing bioavailability, and addressing long-term toxicological outcomes, thereby reinforcing HT's potential as a high-value functional ingredient in various industries.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.